Lupin launches generic contraceptive drug in US
PTI, Apr 7, 2022, 4:54 PM IST
New Delhi: Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market.
The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, Lupin Ltd said in a statement.
Slayback had earlier launched this product in the US in February 2021.
Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals’ Taytulla capsules.
As per IQVIA MAT February 2022 data, Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules, 1 mg/20 mcg had estimated annual sales of USD 90 million in the US.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Muscle fat can increase risk of heart disease, regardless of BMI, study finds
Pregnant woman’s grey matter shrinks by 5%, partly recovers postpartum, study finds
Eye’s retina can indicate risk of stroke without lab tests, study suggests
Surgical infection rate higher in India than many high-income countries: ICMR Study
Want to ward off the winter blues? Start by counting your steps – new research
MUST WATCH
Latest Additions
Current Congress leaders are fake Gandhis: R. Ashoka
Ramanagara woman dies by suicide allegedly over microfinance harassment, police file case
Animated film ‘Ramayana: The Legend of Prince Ram’ to be screened at Maha Kumbh on Wednesday
Hopeful Trump will work to end war, important to bring Putin to table: Zelenskyy
Praveen Nettaru murder case: NIA arrests 21st accused
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.